Related News

• Which Aerospace and Defense ETF Is the Better Buy: iShares' ITA or First Trust's MISL? | 2026-07-18
  ITA delivered 19% returns over one year with lower costs, while MISL offers unique tech exposure through Palantir.
• NATO's $40 Billion Counter-Drone Push Puts These Defense ETFs in Focus | 2026-07-18
  NATO's $40 billion counter-drone initiative is accelerating defense investment. Here's how ETFs offer exposure to the military drone industry.
• L3Harris (LHX) Lands 18 Space Force Satellites And New Army Orders | 2026-07-18
  L3Harris Technologies secured a contract from the U.S. Space Force’s Space Development Agency for 18 Accelerated Missile Defense Tranche 3 satellites. The company also received major orders tied to the U.S. Army’s Next Generation Command and Control initiative. These awards expand L3Harris Technologies’ role in missile detection and resilient communications for U.S. defense customers. L3Harris Technologies, traded on the NYSE under ticker NYSE:LHX, sits at a current share price of $282.01...
• Apple briefly overtakes Nvidia as world's most valuable company amid AI investment doubts | 2026-07-17
  Apple briefly overtook Nvidia as the world's most valuable company Friday before the AI chip giant reclaimed its $4.92 trillion market cap by closing bell.
• What's Going on With Northrop Grumman Stock Friday? | 2026-07-17
  Northrop Grumman (NOC) climbs as tech money rotates into defense. With Q2 earnings days away, here is what Wall Street expects.
• Wall St Week Ahead Alphabet, Intel results in focus for AI trade as US earnings rev up | 2026-07-17
  U.S. corporate earnings season heats up in the coming week, with Alphabet and Intel set to offer updates that could sway the market-leading AI trade and investors ​eager to see if companies can meet high profit expectations to help the U.S. stock market weather uncertainty over the Iran war.
• Kalshi to offer betting on drug trial results and FDA regulatory decisions | 2026-07-16
  Move comes as prediction platforms rapidly gain popularity and offer opportunities to bet on virtually anythingKalshi is expanding its wagers to include bets on drug trial results, an expansion into new predictions territory as platforms continue to rapidly gain popularity and offer opportunities to bet on virtually anything.The betting platform said the expansion into clinical trials and FDA regulatory decisions would help surface information on drug trials that otherwise go unreported. A publicly listed contract on a drug trial would produce a “continuously updated, public probability that reflects the weight of the evidence, rather than the preferred message of the trial sponsor”, the company said. Continue reading...
• The Bull Case For RTX (RTX) Could Change Following Major UK Training Win And AI Advances | 2026-07-16
  In July 2026, Omnia Training announced a £2.00 billion, 15-year UK Ministry of Defence contract for the British Army’s digitally enabled collective training, led by RaytheonUK alongside Capita, Cervus, Rheinmetall UK and Skyral, while RTX’s Raytheon and Pratt & Whitney units advanced missile defense and AI-driven engine inspection capabilities. Together, these moves highlight RTX’s push deeper into high-tech defence training, next-generation interceptors and AI-enabled aerospace maintenance,...
• Japan’s Robotics and Manufacturing Leaders Build on NVIDIA Cosmos to Advance Physical AI Frontier | 2026-07-16
  News Summary:
• Kalshi to Offer Contracts Predicting Flight Cancellations | 2026-07-15
  The contracts will allow users to predict the percentages of flights canceled at an airport within a given timeframe.

News source: finlight